A computational study of metal ions interaction with amyloid-β 1-42 peptide structure in hyperpyrexia: Implications for Alzheimer disease.

Alzheimer’s disease Conformational analysis Hyperpyrexia In silico investigations Intracranial pressure Metal interactions

Journal

Journal of King Saud University. Science
ISSN: 2213-686X
Titre abrégé: J King Saud Univ Sci
Pays: Saudi Arabia
ID NLM: 9886378

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 14 07 2021
revised: 08 06 2022
accepted: 13 06 2022
pubmed: 6 7 2022
medline: 6 7 2022
entrez: 5 7 2022
Statut: ppublish

Résumé

Given the current context of the SARS-CoV-19 pandemic, among the interfering risky factors with the Aβ peptide aggregation in the brains of Alzheimer's disease (AD) patients can be hyperpyrexia and increased intracranial pressure (ICP). According to our hypothesis on the relationship between hyperpyrexia and cognitive decline in AD, two models of Aβ peptides were used in this study: the structure of AD amyloid beta-peptide and near-atomic resolution fibril structures of the Aβ peptide. Therefore, the binding templates were constructed for Aβ peptide regions able to bind 9 different metal ions. The fragment transformation method was used for the structural comparison between Aβ chains. Molecular dynamics simulation (MDS) was applied using the Nose-Poincare-Anderson equation to generate a theoretically correct NPT (isothermal-isobaric ensemble). The smallest dissimilarities were observed in the case of Cu

Identifiants

pubmed: 35783243
doi: 10.1016/j.jksus.2022.102184
pii: S1018-3647(22)00365-2
pmc: PMC9238029
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102184

Informations de copyright

© 2022 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

J Am Chem Soc. 2008 Jan 30;130(4):1376-83
pubmed: 18179213
Eur J Pediatr. 2020 Feb;179(2):353
pubmed: 31754775
Biomolecules. 2014 Jan 10;4(1):101-16
pubmed: 24970207
Brain Sci. 2016 Feb 17;6(1):
pubmed: 26901230
J Biol Chem. 2010 Dec 31;285(53):41533-40
pubmed: 20974842
Science. 2017 Oct 6;358(6359):116-119
pubmed: 28882996
Lancet. 2000 Sep 9;356(9233):923-9
pubmed: 11036909
Nat Chem Biol. 2011 Nov 20;8(1):93-101
pubmed: 22101602
Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17342-7
pubmed: 16293696
Transl Neurodegener. 2020 Apr 3;9:10
pubmed: 32266063
FASEB J. 2004 Sep;18(12):1427-9
pubmed: 15231727
Chempluschem. 2022 Feb;87(2):e202100462
pubmed: 35104052
Acc Chem Res. 2014 Aug 19;47(8):2252-9
pubmed: 24871565
Curr Drug Targets. 2020;21(2):148-166
pubmed: 31385768
Phys Chem Chem Phys. 2019 Apr 24;21(17):8774-8784
pubmed: 30968896
Crit Care Explor. 2020 Sep 15;2(9):e0213
pubmed: 32984835
Biochemistry. 2012 Feb 28;51(8):1697-706
pubmed: 22283439
Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006189
pubmed: 22229116
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5129-34
pubmed: 10805776
J Biol Chem. 1999 Dec 24;274(52):37111-6
pubmed: 10601271
J Inorg Biochem. 2020 Apr;205:110996
pubmed: 31954342
PLoS One. 2012;7(6):e39252
pubmed: 22723976
Crit Care. 2014 Oct 14;18(5):552
pubmed: 25311035
Inorg Chem. 2013 Nov 4;52(21):12193-206
pubmed: 23607830
J Chem Inf Model. 2016 Dec 27;56(12):2287-2291
pubmed: 27976886
Mol Neurodegener. 2020 Jul 16;15(1):40
pubmed: 32677986
Annu Rev Neurosci. 2007;30:317-37
pubmed: 17367269
Eur J Biochem. 2002 Nov;269(22):5642-8
pubmed: 12423364
Hypertension. 2005 Apr;45(4):705-9
pubmed: 15738350
Elife. 2020 Feb 05;9:
pubmed: 32022689
Alzheimers Dement. 2014 Mar;10(2):e40-6
pubmed: 24698031
Molecules. 2020 Oct 03;25(19):
pubmed: 33022965
J Chem Inf Model. 2019 May 28;59(5):1782-1805
pubmed: 30933519
Arch Neurol. 2007 Jul;64(7):954-6
pubmed: 17620484
Front Neurol. 2020 Jan 10;10:1312
pubmed: 31998208
Pharmaceuticals (Basel). 2021 Oct 01;14(10):
pubmed: 34681235
Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):315-20
pubmed: 15630094
Interdiscip Sci. 2010 Mar;2(1):57-69
pubmed: 20640797
J Biol Chem. 2011 Jul 29;286(30):26952-63
pubmed: 21642429
J Chem Inf Model. 2017 Jun 26;57(6):1342-1358
pubmed: 28474890

Auteurs

Cosmin Stefan Mocanu (CS)

Faculty of Chemistry, "Al. I. Cuza" University of Iasi, 11 Carol I, Iasi 70605, Romania.

Laura Darie-Ion (L)

Faculty of Chemistry, "Al. I. Cuza" University of Iasi, 11 Carol I, Iasi 70605, Romania.

Brindusa Alina Petre (BA)

Faculty of Chemistry, "Al. I. Cuza" University of Iasi, 11 Carol I, Iasi 70605, Romania.
Center for Fundamental Research and Experimental Development in Translation Medicine, Regional Institute of Oncology, 2-4 General Henri Mathias Berthelot Str., 700483 Iasi, Romania.

Vasile Robert Gradinaru (VR)

Faculty of Chemistry, "Al. I. Cuza" University of Iasi, 11 Carol I, Iasi 70605, Romania.

Gabi Drochioiu (G)

Faculty of Chemistry, "Al. I. Cuza" University of Iasi, 11 Carol I, Iasi 70605, Romania.

Classifications MeSH